Cigna Group Investment Insights: Performance and Analyst Ratings
Angeles Wealth Management LLC has significantly increased its investment in Cigna Group's stock during the third quarter, according to its latest SEC filing. The firm acquired an additional 5,583 shares, elevating its total to 7,972 shares valued at $2,298,000 by the end of the reporting period.
Other institutional investors and hedge funds have also adjusted their stakes in Cigna Group. Brighton Jones LLC increased its investment by 9.3% in the fourth quarter, acquiring 3,736 shares worth $1,032,000. Similarly, Sivia Capital Partners LLC raised its holdings by 10.4% in the second quarter to 1,160 shares valued at $384,000. Crestwood Advisors Group LLC enhanced its stake by 14.5% in the same period, holding 1,743 shares worth $576,000. Additionally, Atlantic Union Bankshares Corp initiated a new position valued at approximately $3,118,000 in the second quarter. Overall, institutional investors control around 86.99% of Cigna Group’s stock.
In corporate insider activity, Nicole S. Jones sold 2,307 shares of Cigna stock, reducing her ownership by 6.60%, while Everett Neville decreased his stake by 23.26% after selling 1,719 shares. These transactions were detailed in recent SEC filings, underlining the dynamic nature of insider stock activities.
Cigna Group has been the subject of recent analyst reports. Zacks Research upgraded Cigna from a "strong sell" to a "hold." Piper Sandler adjusted its target price from $374 to $370, assigning an "overweight" rating. Deutsche Bank Aktiengesellschaft increased their price target from $301 to $304 with a "buy" rating. Robert W. Baird reduced their price objective from $372 to $315, maintaining an "outperform" rating. Truist Financial raised their target price from $320 to $350, issuing a "buy" rating. Currently, Cigna holds a consensus "Moderate Buy" rating with an average price target of $330.42 from multiple analyst insights.
On the financial front, Cigna's shares opened at $271.50 with a market capitalization of $71.55 billion, accompanied by a P/E ratio of 12.24 and a beta of 0.27. In its recent earnings report, Cigna posted an $8.08 EPS for the quarter, surpassing the anticipated $7.88, with revenue at $72.50 billion. The company aims to achieve an EPS of 30.250 by FY 2026 and recently announced a quarterly dividend payout of $1.56 per share, reinforcing its commitment to returning value to shareholders.
Cigna Group operates as a global health services provider, offering a variety of healthcare products and insurance solutions spanning medical, behavioral, dental, and pharmacy benefit plans. The company serves commercial, Medicare, and Medicaid markets and provides group health and supplemental benefits for employers. Cigna is also engaged in managing healthcare delivery to control costs and enhance health outcomes.